Name: HALO Income Statement - Halozyme Therapeutics Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

HALO - Halozyme Therapeutics, Inc.

USD | NASDAQ | Healthcare

HALO Income Statement - Halozyme Therapeutics Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	376.7	451.8	354.3	325.7	264.9	298.0	290.1	231.4	195.9	230.0	216.0	221.0	162.1	181.5	209.0	152.4

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Revenues
Revenues	1,508.5	1,396.6	1,015.3	829.3	660.1	443.3	267.6	196.0	151.9	316.6	146.7	135.1	75.3	54.8	42.3	56.1	13.6	13.7
Cost of Revenue	259.6	228.8	159.4	192.4	139.3	81.4	43.4	45.5	10.1	31.2	33.2	29.2	22.7	6.2	1.1	0.3	1.0	0.3
Gross Profit	1,248.8	1,167.8	855.9	636.9	520.8	361.9	224.2	150.4	141.7	285.5	113.5	105.8	52.6	48.6	41.2	55.8	12.6
Operating Expenses
Research & Development	-	-	79.0	76.4	66.6	35.7	34.2	140.8	150.3	150.6	150.8	93.2	79.7	96.6	70.0
Operating Income
Operating Income	512.0	469.0	551.5	337.6	267.5	275.9	144.3	(67.6)	(69.3)	81.0	(83.2)	(27.5)	(63.0)	(80.4)
Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Tax & Net
Income Tax Expense	154.5	150.0	113.0	66.7	46.8	(154.2)	0.2	(0.0)	0.5	(1.4)	1.2	0.0	0.0	-	-
Per Share
EPS Basic	2.95	2.64	3.50	2.13	1.48	2.86	0.95	(0.50)	(0.56)	0.46	(0.81)	(0.25)	-	-	-	-
Supplementary Data
EBITDA	524.9	480.4	561.7	348.7	274.0	278.9	147.5	(63.5)	(66.9)	83.2	(80.8)	(25.8)	(61.3)	(79.2)	(52.5)	(18.7)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	25.6	-	17.3	17.5	14.8	20.4	18.5	21.0	19.1	21.3	17.3	19.7	18.0	22.6	16.7	15.5	11.9	10.1	8.5	8.1	9.0	7.4	7.7	9.0	10.2	45.1	30.5	33.9	31.3	36.7	35.5	40.1	38.0	41.4	34.0	38.3	36.9	41.3	33.9	35.5
Selling General & Administrative	57.9	77.0	46.1	41.6	42.4	42.2	41.2	35.7	35.1	37.6	35.3	38.9	37.4	37.7	34.5	57.5
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	4.2	3.3	2.7	2.7	2.7	2.6	2.6	2.6	2.4	3.0	2.7	2.8	2.6	2.6	2.0	1.1
Amortization of Intangibles	29.5	23.4	17.8	17.8	17.8	17.8	17.8	17.8	17.8	17.8	20.3	17.8	17.8	4.6	27.2	11.4
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	192.2	544.7	136.3	123.3	123.3	122.5	126.9	114.1	100.3	129.0	127.8	126.6	108.3	107.0	125.7	118.3

Operating Income
Operating Income	184.5	(92.9)	217.9	202.4	141.5	175.5	163.2	117.2	95.5	101.0	88.3	94.5	53.8	74.5	83.3	34.1	75.7	56.5	75.6	93.0	50.7	77.6	40.3	29.6	(3.2)	(32.1)	(24.5)	(14.0)	3.0	(0.1)	(25.5)	(20.1)	(23.7)	125.9	8.1	(25.5)	(27.5)	(22.6)	(22.7)	(21.7)

Tax & Net
Income Tax Expense	30.3	40.7	43.7	39.8	25.7	41.2	28.1	24.5	19.2	15.8	19.9	18.4	12.6	13.1	12.1	7.3	14.3	(12.0)	(142.5)	0.1	0.2	0.1	0.1	0.1	0.0	(0.1)	0.0	0.0	0.0	0.3	0.0	0.0	0.2	(2.3)	0.6	0.2	0.2	(0.4)	1.3	0.3
Net Income From Continuing Ops	150.0	(141.6)	175.2	165.2	118.1	137.0	137.0	93.2	76.8	85.4	81.8	74.8	39.6	57.7	61.6	22.7	60.1
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	150.0	(141.6)	175.2	165.2	118.1	137.0	137.0	93.2	76.8	85.4	81.8	74.8	39.6	57.7	61.6	22.7	60.1
Net Income Attributable To Parent	150.0	(141.6)	175.2	165.2	118.1	137.0	137.0	93.2	76.8	85.4	81.8	74.8	39.6	57.7	61.6	22.7
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	150.0	(141.6)	175.2	165.2	118.1	137.0	137.0	93.2	76.8	85.4	81.8	74.8	39.6	57.7	61.6

Per Share
EPS Basic	1.27	-	1.49	1.36	0.96	-	1.08	0.73	0.61	-	0.62	0.57	0.29	-	0.45	0.16	0.44	-	1.53	0.64	0.20	-	0.27	0.19	(0.04)	-	(0.17)	-	0.01	-	(0.19)	(0.16)	(0.19)	-	0.02	(0.23)	(0.26)	-	(0.23)	(0.21)
EPS Diluted	1.22	-	1.43	1.33	0.93	-	1.05	0.72	0.60	-	0.61	0.56	0.29	-	0.44	0.16	0.43	-
Shares Basic	118.1	-	117.2	121.3	123.2	-	126.9	127.1	126.9	-	132.0	131.7	135.0	-	136.5	137.9	137.7	-
Shares Diluted	122.9	-	122.3	124.2	126.6	-	130.1	129.2	128.9	-	134.1	133.5	137.9	-	139.4	142.2	141.3	-

Supplementary Data
EBITDA	188.7	(89.6)	220.6	205.1	144.2	178.1	165.8	119.8	98.0	104.0	91.0	97.3	56.4	77.1	85.3	35.2	76.4	57.3	76.3	93.8	51.5	78.5	41.1	30.4	(2.4)	(31.0)	(23.5)	(13.0)	4.0	0.6	(24.9)	(19.5)	(23.1)	126.4	8.6	(24.9)	(26.9)	(22.0)	(22.0)	(21.1)
EBIT	184.5	(92.9)	217.9	202.4	141.5	175.5	163.2	117.2	95.5	101.0	88.3	94.5	53.8	74.5	83.3	34.1	75.7	56.5	75.6

Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	5.5	4.9	4.3	4.4	4.5	4.5	4.5	4.5	4.5	5.2	4.5	4.5	4.5	4.6	7.5	3.1	1.8	2.1
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	1.3	2.4	5.3	6.9	6.8	7.3	6.5	5.0	5.0	5.4	4.8	3.2	3.0	0.9	0.6	(0.9)	0.5
Pre-Tax Income	180.3	(100.8)	219.0	204.9	143.8	178.2	165.1	117.7	96.0	101.2	101.8	93.2	52.2	70.8	73.7	30.0